(Total Views: 628)
Posted On: 05/31/2020 9:18:19 PM
Post# of 155188
Re: Rubraquercus #36031
On Friday, I Sent someone at the YaleNewHaven System the following via email:
"I understand Yale is involved with a trial for a drug that's undergoing studies for Covid-19. It is called LERONLIMAB. Is there anyone I can get in touch with about this trial?"
Here's the response I received within an hour:
"Thank you for your email. All of the Yale School of Medicine clinical trials related to COVID-19 are listed online at https://covid.yale.edu/trials/volunteers/ along with other relevant research information.
Please let me know if you need anything else."
I responded back:
"Thank you for sending me this information Renee.
I see in the Inpatient Trials use of Remdesivir and also Sarilumab but unfortunately neither works as well as Leronlimab. I hope Yale would check further into it for the sake of many a patient.
In any case, thanks for responding and the information."
"I understand Yale is involved with a trial for a drug that's undergoing studies for Covid-19. It is called LERONLIMAB. Is there anyone I can get in touch with about this trial?"
Here's the response I received within an hour:
"Thank you for your email. All of the Yale School of Medicine clinical trials related to COVID-19 are listed online at https://covid.yale.edu/trials/volunteers/ along with other relevant research information.
Please let me know if you need anything else."
I responded back:
"Thank you for sending me this information Renee.
I see in the Inpatient Trials use of Remdesivir and also Sarilumab but unfortunately neither works as well as Leronlimab. I hope Yale would check further into it for the sake of many a patient.
In any case, thanks for responding and the information."
(0)
(0)
